EACS2023: 144 Role of the Advanced Pharmacist Practitioner (APP) H. Mohammed , N. Naous , E. Dwyer , M. Boffito , R. Jones Chelsea & Westminster Hospital NHS Trust, London, United Kingdom General data Abstract category: Access and delivery of care Abstract body Purpose: Pharmacists are medicines experts and momentum exists in the UK for enhanced clinical roles. Delivery of pharmacist-led care within the UK varies and usually supplements the routine physician appointment. To preserve continuity of our services, a pharmacist was recruited to a vacant nurse practitioner role. The APP worked independently to deliver clinics for PLWH and manage an entire episode of care. Method: Prospective data collection of consultations conducted over a 12 month period. Online surveys were distributed to capture MDT opinion of the APP role. In order to assess feasibility of this model, a separate survey was distributed to HIV pharmacists via UK networks to understand drivers, barriers and appetite for the role. Satisfaction survey data was collected from PLWH. Results: The APP conducted 500 consultations during the 12 month period: 93% in-person. Overall, 435 PLWH were reviewed (table 1). Table 1: characteristics of PLWH reviewed by the APP (n=435) Median age (range) % female Mean number of co-morbidities (range) Mean number of co-medications (range) % virologically suppressed (VL <50 c/ml) 53 (26-91) 28% 2 (0-14) 3 (0-24) 90% Of those with viraemia (VL >200 c/ml), 15/25 demonstrated a one log VL drop at subsequent attendance. Senior advice was sought for 5% of consultations. Table 2 illustrates breakdown of interventions made by the APP. Table 2: Interventions made by the APP Intervention n (PLWH) Imaging requested (BMD/CT CACS/liver USS) 116 (93) Referral to other specialities 99 (90) Initiate or switch ARVs 83 (82) Medicines optimisation (e.g. initiate/titrate non-ARVs, deprescribing) 58 (56) Vaccine prescribed (Hep A/B, HPV, MPV) 55 (45) A total of 30/55 HCPs responded to the survey: 97% strongly agreed that APPs should be included in future business planning. Of the pharmacists surveyed, 78% (21/27) expressed interest in working in an APP role. Amongst PLWH respondents (n=18), 72% felt the APP exceeded care expectations. Conclusions: We demonstrate the successful utilisation of a novel role within HIV services. The APP delivered holistic care, encompassing medically complex PLWH and those with viraemia. The unique skillset of HIV specialist pharmacists should be harnessed to consolidate MDTs and address EU workforce shortages. With rising polypharmacy, APPs are well positioned to deliver medicines optimisation and co-morbidity management to an ageing cohort of PLWH. General conditions 1. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after the submission deadline and I am aware that it will be published exactly as submitted.: Yes 2. I confirm that the submission of the abstract constitutes my consent to publication (e.g. conference website, programmes, other promotions, etc.). : Yes 3. I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.: Yes 4. I agree that all data provided may be used (saved, stored, processed, transmitted and deleted) in compliance with the privacy policy to provide the services described.: Yes 1 1 1 1 1 1 10 11
RkJQdWJsaXNoZXIy Mzc2ODc=